XML 12 R39.htm IDEA: XBRL DOCUMENT
v2.4.0.8

Guarantor and Non-Guarantor Financial Statements (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2014
Guarantor and Non-Guarantor Financial Statement [Abstract] |
Schedule of Condensed Financial Statements | CONDENSED CONSOLIDATING BALANCE SHEET September 30, 2014
|  | Parent |  | Guarantor Subsidiaries |  | Non-Guarantor Subsidiaries |  | Consolidating Adjustments |  | Consolidated
ASSETS |  |  |  |  |  |  |  |  |  |
Current assets: |  |  |  |  |  |  |  |  |  |
Cash and cash equivalents |  | $ | — |  |  | $ | 208.6 |  |  | $ | 3.7 |  |  | $ | — |  |  | $ | 212.3 |
Short-term investments |  | — |  |  | 100.1 |  |  | — |  |  | — |  |  | 100.1 |
Receivables: |  |  |  |  |  |  |  |  |  |
Trade, less allowance for doubtful receivables |  | — |  |  | 128.0 |  |  | 4.4 |  |  | — |  |  | 132.4 |
Intercompany receivables |  | — |  |  | 34.0 |  |  | 1.0 |  |  | (35.0 | ) |  | — |
Other |  | — |  |  | 5.1 |  |  | 5.3 |  |  | — |  |  | 10.4 |
Inventories |  | — |  |  | 205.5 |  |  | 6.6 |  |  | (0.8 | ) |  | 211.3 |
Prepaid expenses and other current assets |  | 100.1 |  |  | 55.9 |  |  | 0.4 |  |  | — |  |  | 156.4 |
Total current assets |  | 100.1 |  |  | 737.2 |  |  | 21.4 |  |  | (35.8 | ) |  | 822.9 |
Investments in and advances to subsidiaries |  | 1,531.5 |  |  | 29.6 |  |  | — |  |  | (1,561.1 | ) |  | — |
Property, plant, and equipment — net |  | — |  |  | 426.9 |  |  | 16.0 |  |  | — |  |  | 442.9 |
Long-term intercompany receivables |  | — |  |  | — |  |  | 16.5 |  |  | (16.5 | ) |  | — |
Net assets of VEBAs |  | — |  |  | 430.3 |  |  | — |  |  | — |  |  | 430.3 |
Deferred tax assets — net |  | — |  |  | 17.8 |  |  | — |  |  | 8.9 |  |  | 26.7 |
Intangible assets — net |  | — |  |  | 32.5 |  |  | — |  |  | — |  |  | 32.5 |
Goodwill |  | — |  |  | 37.2 |  |  | — |  |  | — |  |  | 37.2 |
Other assets |  | 4.6 |  |  | 19.1 |  |  | 0.1 |  |  | — |  |  | 23.8 |
Total |  | $ | 1,636.2 |  |  | $ | 1,730.6 |  |  | $ | 54.0 |  |  | $ | (1,604.5 | ) |  | $ | 1,816.3 |
LIABILITIES AND STOCKHOLDERS’ EQUITY |  |  |  |  |  |  |  |  |  |
Current liabilities: |  |  |  |  |  |  |  |  |  |
Accounts payable |  | $ | 0.7 |  |  | $ | 80.8 |  |  | $ | 7.8 |  |  | $ | — |  |  | $ | 89.3 |
Intercompany payable |  | 30.2 |  |  | 11.5 |  |  | 3.1 |  |  | (44.8 | ) |  | — |
Accrued salaries, wages, and related expenses |  | — |  |  | 33.7 |  |  | 3.5 |  |  | — |  |  | 37.2 |
Other accrued liabilities |  | 109.4 |  |  | 22.1 |  |  | 0.2 |  |  | — |  |  | 131.7 |
Current portion of long-term debt |  | 170.2 |  |  | — |  |  | — |  |  | — |  |  | 170.2 |
Short-term capital lease |  | — |  |  | 0.1 |  |  | — |  |  | — |  |  | 0.1 |
Total current liabilities |  | 310.5 |  |  | 148.2 |  |  | 14.6 |  |  | (44.8 | ) |  | 428.5 |
Deferred tax liability |  | — |  |  | — |  |  | 1.2 |  |  | — |  |  | 1.2 |
Long-term intercompany payable |  | — |  |  | 16.5 |  |  | — |  |  | (16.5 | ) |  | — |
Long-term liabilities |  | — |  |  | 50.7 |  |  | 10.2 |  |  | — |  |  | 60.9 |
Long-term debt |  | 225.0 |  |  | — |  |  | — |  |  | — |  |  | 225.0 |
Total liabilities |  | 535.5 |  |  | 215.4 |  |  | 26.0 |  |  | (61.3 | ) |  | 715.6 |
Total stockholders’ equity |  | 1,100.7 |  |  | 1,515.2 |  |  | 28.0 |  |  | (1,543.2 | ) |  | 1,100.7 |
Total |  | $ | 1,636.2 |  |  | $ | 1,730.6 |  |  | $ | 54.0 |  |  | $ | (1,604.5 | ) |  | $ | 1,816.3 |
CONDENSED CONSOLIDATING BALANCE SHEET December 31, 2013
|  | Parent |  | Guarantor Subsidiaries |  | Non-Guarantor Subsidiaries |  | Consolidating Adjustments |  | Consolidated
ASSETS |  |  |  |  |  |  |  |  |  |
Current assets: |  |  |  |  |  |  |  |  |  |
Cash and cash equivalents |  | $ | 5.0 |  |  | $ | 157.7 |  |  | $ | 6.8 |  |  | $ | — |  |  | $ | 169.5 |
Short-term investments |  | — |  |  | 129.5 |  |  | — |  |  | — |  |  | 129.5 |
Receivables: |  |  |  |  |  |  |  |  |  |
Trade, less allowance for doubtful receivables |  | — |  |  | 117.7 |  |  | 2.1 |  |  | — |  |  | 119.8 |
Intercompany receivables |  | — |  |  | 0.1 |  |  | 0.2 |  |  | (0.3 | ) |  | — |
Other |  | — |  |  | 5.3 |  |  | 8.1 |  |  | — |  |  | 13.4 |
Inventories |  | — |  |  | 208.6 |  |  | 6.4 |  |  | (0.6 | ) |  | 214.4 |
Prepaid expenses and other current assets |  | 0.1 |  |  | 43.7 |  |  | 0.4 |  |  | — |  |  | 44.2 |
Total current assets |  | 5.1 |  |  | 662.6 |  |  | 24.0 |  |  | (0.9 | ) |  | 690.8 |
Investments in and advances to subsidiaries |  | 1,437.9 |  |  | 26.5 |  |  | — |  |  | (1,464.4 | ) |  | — |
Property, plant, and equipment — net |  | — |  |  | 414.0 |  |  | 15.3 |  |  | — |  |  | 429.3 |
Long-term intercompany receivables |  | 31.3 |  |  | 1.6 |  |  | 9.5 |  |  | (42.4 | ) |  | — |
Net assets of VEBAs |  | — |  |  | 406.0 |  |  | — |  |  | — |  |  | 406.0 |
Deferred tax assets — net |  | — |  |  | 60.2 |  |  | — |  |  | 8.9 |  |  | 69.1 |
Intangible assets — net |  | — |  |  | 33.7 |  |  | — |  |  | — |  |  | 33.7 |
Goodwill |  | — |  |  | 37.2 |  |  | — |  |  | — |  |  | 37.2 |
Other assets |  | 86.2 |  |  | 18.5 |  |  | 0.1 |  |  | — |  |  | 104.8 |
Total |  | $ | 1,560.5 |  |  | $ | 1,660.3 |  |  | $ | 48.9 |  |  | $ | (1,498.8 | ) |  | $ | 1,770.9 |
LIABILITIES AND STOCKHOLDERS’ EQUITY |  |  |  |  |  |  |  |  |  |
Current liabilities: |  |  |  |  |  |  |  |  |  |
Accounts payable |  | $ | 1.1 |  |  | $ | 56.3 |  |  | $ | 5.5 |  |  | $ | — |  |  | $ | 62.9 |
Intercompany payable |  | — |  |  | 13.9 |  |  | 0.1 |  |  | (14.0 | ) |  | — |
Accrued salaries, wages, and related expenses |  | — |  |  | 39.3 |  |  | 3.4 |  |  | — |  |  | 42.7 |
Other accrued liabilities |  | 3.5 |  |  | 39.9 |  |  | 1.4 |  |  | — |  |  | 44.8 |
Short-term capital lease |  | — |  |  | 0.2 |  |  | — |  |  | — |  |  | 0.2 |
Total current liabilities |  | 4.6 |  |  | 149.6 |  |  | 10.4 |  |  | (14.0 | ) |  | 150.6 |
Deferred tax liability |  | — |  |  | — |  |  | 1.2 |  |  | — |  |  | 1.2 |
Long-term intercompany payable |  | — |  |  | 40.7 |  |  | 1.7 |  |  | (42.4 | ) |  | — |
Long-term liabilities |  | 83.2 |  |  | 52.0 |  |  | 11.2 |  |  | — |  |  | 146.4 |
Long-term debt |  | 388.5 |  |  | — |  |  | — |  |  | — |  |  | 388.5 |
Total liabilities |  | 476.3 |  |  | 242.3 |  |  | 24.5 |  |  | (56.4 | ) |  | 686.7 |
Total stockholders’ equity |  | 1,084.2 |  |  | 1,418.0 |  |  | 24.4 |  |  | (1,442.4 | ) |  | 1,084.2 |
Total |  | $ | 1,560.5 |  |  | $ | 1,660.3 |  |  | $ | 48.9 |  |  | $ | (1,498.8 | ) |  | $ | 1,770.9 |
CONDENSED CONSOLIDATING STATEMENT OF COMPREHESIVE INCOME Quarter Ended September 30, 2014
|  | Parent |  | Guarantor Subsidiaries |  | Non-Guarantor Subsidiaries |  | Consolidating Adjustments |  | Consolidated
Net sales |  | $ | — |  |  | $ | 330.3 |  |  | $ | 33.6 |  |  | $ | (25.0 | ) |  | $ | 338.9 |
Costs and expenses: |  |  |  |  |  |  |  |  |  |
Cost of products sold: |  |  |  |  |  |  |  |  |  |
Cost of products sold, excluding depreciation and amortization and other items |  | — |  |  | 274.7 |  |  | 29.8 |  |  | (24.1 | ) |  | 280.4 |
Unrealized gains on derivative instruments |  | — |  |  | 3.6 |  |  | — |  |  | — |  |  | 3.6 |
Depreciation and amortization |  | — |  |  | 7.7 |  |  | 0.3 |  |  | — |  |  | 8.0 |
Selling, administrative, research and development, and general |  |  |  |  |  |  |  |  |  |
Selling, administrative, research and development, and general |  | 0.9 |  |  | 17.2 |  |  | 1.7 |  |  | (0.8 | ) |  | 19.0 |
Net periodic pension benefit income relating to VEBAs |  | — |  |  | (6.0 | ) |  | — |  |  | — |  |  | (6.0 | )
Total selling, administrative, research and development, and general |  | 0.9 |  |  | 11.2 |  |  | 1.7 |  |  | (0.8 | ) |  | 13.0 |
Other operating charges, net |  | — |  |  | 1.3 |  |  | — |  |  | — |  |  | 1.3 |
Total costs and expenses |  | 0.9 |  |  | 298.5 |  |  | 31.8 |  |  | (24.9 | ) |  | 306.3 |
Operating (loss) income |  | (0.9 | ) |  | 31.8 |  |  | 1.8 |  |  | (0.1 | ) |  | 32.6 |
Other (expense) income: |  |  |  |  |  |  |  |  |  |
Interest expense |  | (9.4 | ) |  | (0.5 | ) |  | — |  |  | 0.2 |  |  | (9.7 | )
Other income (expense), net |  | 2.2 |  |  | 0.3 |  |  | (0.1 | ) |  | (0.2 | ) |  | 2.2 |
(Loss) income before income taxes |  | (8.1 | ) |  | 31.6 |  |  | 1.7 |  |  | (0.1 | ) |  | 25.1 |
Income tax (provision) benefit |  | — |  |  | (11.9 | ) |  | (0.1 | ) |  | 2.8 |  |  | (9.2 | )
Earnings in equity of subsidiaries |  | 24.0 |  |  | 1.6 |  |  | — |  |  | (25.6 | ) |  | — |
Net income |  | $ | 15.9 |  |  | $ | 21.3 |  |  | $ | 1.6 |  |  | $ | (22.9 | ) |  | $ | 15.9 |
Comprehensive income |  | $ | 17.2 |  |  | $ | 22.5 |  |  | $ | 1.7 |  |  | $ | (24.2 | ) |  | $ | 17.2 |
CONDENSED CONSOLIDATING STATEMENT OF COMPREHESIVE INCOME Nine Months Ended September 30, 2014
|  | Parent |  | Guarantor Subsidiaries |  | Non-Guarantor Subsidiaries |  | Consolidating Adjustments |  | Consolidated
Net sales |  | $ | — |  |  | $ | 993.1 |  |  | $ | 100.7 |  |  | $ | (75.7 | ) |  | $ | 1,018.1 |
Costs and expenses: |  |  |  |  |  |  |  |  |  |
Cost of products sold: |  |  |  |  |  |  |  |  |  |
Cost of products sold, excluding depreciation and amortization and other items |  | — |  |  | 824.4 |  |  | 87.9 |  |  | (73.5 | ) |  | 838.8 |
Depreciation and amortization |  | — |  |  | 22.3 |  |  | 0.8 |  |  | — |  |  | 23.1 |
Selling, administrative, research and development, and general |  |  |  |  |  |  |  |  |  |
Selling, administrative, research and development, and general |  | 3.1 |  |  | 52.3 |  |  | 7.9 |  |  | (2.0 | ) |  | 61.3 |
Net periodic pension benefit income relating to VEBAs |  | — |  |  | (17.7 | ) |  | — |  |  | — |  |  | (17.7 | )
Total selling, administrative, research and development, and general |  | 3.1 |  |  | 34.6 |  |  | 7.9 |  |  | (2.0 | ) |  | 43.6 |
Other operating charges, net |  | — |  |  | 1.5 |  |  | — |  |  | — |  |  | 1.5 |
Total costs and expenses |  | 3.1 |  |  | 882.8 |  |  | 96.6 |  |  | (75.5 | ) |  | 907.0 |
Operating (loss) income |  | (3.1 | ) |  | 110.3 |  |  | 4.1 |  |  | (0.2 | ) |  | 111.1 |
Other (expense) income: |  |  |  |  |  |  |  |  |  |
Interest expense |  | (28.0 | ) |  | (0.1 | ) |  | — |  |  | 0.4 |  |  | (27.7 | )
Other income, net |  | 3.6 |  |  | 2.3 |  |  | 0.4 |  |  | (0.4 | ) |  | 5.9 |
(Loss) income before income taxes |  | (27.5 | ) |  | 112.5 |  |  | 4.5 |  |  | (0.2 | ) |  | 89.3 |
Income tax (provision) benefit |  | — |  |  | (42.3 | ) |  | (0.9 | ) |  | 10.1 |  |  | (33.1 | )
Earnings in equity of subsidiaries |  | 83.7 |  |  | 3.4 |  |  | — |  |  | (87.1 | ) |  | — |
Net income |  | $ | 56.2 |  |  | $ | 73.6 |  |  | $ | 3.6 |  |  | $ | (77.2 | ) |  | $ | 56.2 |
Comprehensive income |  | $ | 60.5 |  |  | $ | 77.7 |  |  | $ | 3.8 |  |  | $ | (81.5 | ) |  | $ | 60.5 |
CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME Quarter Ended September 30, 2013
|  | Parent |  | Guarantor Subsidiaries |  | Non-Guarantor Subsidiaries |  | Consolidating Adjustments |  | Consolidated
Net sales |  | $ | — |  |  | $ | 315.1 |  |  | $ | 29.1 |  |  | $ | (24.3 | ) |  | $ | 319.9 |
Costs and expenses: |  |  |  |  |  |  |  |  |  |
Cost of products sold: |  |  |  |  |  |  |  |  |  |
Cost of products sold, excluding depreciation and amortization and other items |  | — |  |  | 255.8 |  |  | 26.8 |  |  | (23.1 | ) |  | 259.5 |
Unrealized losses on derivative instruments |  | — |  |  | (1.5 | ) |  | — |  |  | — |  |  | (1.5 | )
Depreciation and amortization |  | — |  |  | 6.6 |  |  | 0.3 |  |  | — |  |  | 6.9 |
Selling, administrative, research and development, and general |  |  |  |  |  |  |  |  |  |
Selling, administrative, research and development, and general |  | 1.3 |  |  | 16.9 |  |  | 2.0 |  |  | (1.2 | ) |  | 19.0 |
Net periodic pension benefit income relating to VEBAs |  | — |  |  | (5.6 | ) |  | — |  |  | — |  |  | (5.6 | )
Total selling, administrative, research and development, and general |  | 1.3 |  |  | 11.3 |  |  | 2.0 |  |  | (1.2 | ) |  | 13.4 |
Total costs and expenses |  | 1.3 |  |  | 272.2 |  |  | 29.1 |  |  | (24.3 | ) |  | 278.3 |
Operating (loss) income |  | (1.3 | ) |  | 42.9 |  |  | — |  |  | — |  |  | 41.6 |
Other (expense) income: |  |  |  |  |  |  |  |  |  |
Interest (expense) income |  | (9.2 | ) |  | 0.3 |  |  | — |  |  | 0.1 |  |  | (8.8 | )
Other income, net |  | 2.2 |  |  | 0.5 |  |  | 0.4 |  |  | (0.2 | ) |  | 2.9 |
(Loss) income before income taxes |  | (8.3 | ) |  | 43.7 |  |  | 0.4 |  |  | (0.1 | ) |  | 35.7 |
Income tax (provision) benefit |  | — |  |  | (18.0 | ) |  | 4.4 |  |  | 3.3 |  |  | (10.3 | )
Earnings in equity of subsidiaries |  | 33.7 |  |  | 4.8 |  |  | — |  |  | (38.5 | ) |  | — |
Net income |  | $ | 25.4 |  |  | $ | 30.5 |  |  | $ | 4.8 |  |  | $ | (35.3 | ) |  | $ | 25.4 |
Comprehensive income |  | $ | 26.0 |  |  | $ | 31.4 |  |  | $ | 4.5 |  |  | $ | (35.9 | ) |  | $ | 26.0 |
CONDENSED CONSOLIDATING STATEMENT OF COMPREHESIVE INCOME Nine Months Ended September 30, 2013
|  | Parent |  | Guarantor Subsidiaries |  | Non-Guarantor Subsidiaries |  | Consolidating Adjustments |  | Consolidated
Net sales |  | $ | — |  |  | $ | 971.6 |  |  | $ | 89.1 |  |  | $ | (74.5 | ) |  | $ | 986.2 |
Costs and expenses: |  |  |  |  |  |  |  |  |  |
Cost of products sold: |  |  |  |  |  |  |  |  |  |
Cost of products sold, excluding depreciation and amortization and other items |  | — |  |  | 774.4 |  |  | 80.1 |  |  | (69.9 | ) |  | 784.6 |
Unrealized losses on derivative instruments |  | — |  |  | 3.4 |  |  | — |  |  | — |  |  | 3.4 |
Depreciation and amortization |  | — |  |  | 20.1 |  |  | 0.8 |  |  | — |  |  | 20.9 |
Selling, administrative, research and development, and general |  |  |  |  |  |  |  |  |  |
Selling, administrative, research and development, and general |  | 2.8 |  |  | 57.5 |  |  | 6.5 |  |  | (4.3 | ) |  | 62.5 |
Net periodic pension benefit income relating to VEBAs |  | — |  |  | (16.9 | ) |  | — |  |  | — |  |  | (16.9 | )
Total selling, administrative, research and development, and general |  | 2.8 |  |  | 40.6 |  |  | 6.5 |  |  | (4.3 | ) |  | 45.6 |
Total costs and expenses |  | 2.8 |  |  | 838.5 |  |  | 87.4 |  |  | (74.2 | ) |  | 854.5 |
Operating (loss) income |  | (2.8 | ) |  | 133.1 |  |  | 1.7 |  |  | (0.3 | ) |  | 131.7 |
Other (expense) income: |  |  |  |  |  |  |  |  |  |
Interest expense |  | (27.3 | ) |  | — |  |  | — |  |  | 0.2 |  |  | (27.1 | )
Other income, net |  | 1.7 |  |  | 1.4 |  |  | 0.3 |  |  | (0.3 | ) |  | 3.1 |
(Loss) income before income taxes |  | (28.4 | ) |  | 134.5 |  |  | 2.0 |  |  | (0.4 | ) |  | 107.7 |
Income tax (provision) benefit |  | — |  |  | (52.1 | ) |  | 10.9 |  |  | 11.0 |  |  | (30.2 | )
Earnings in equity of subsidiaries |  | 105.9 |  |  | 12.5 |  |  | — |  |  | (118.4 | ) |  | — |
Net income |  | $ | 77.5 |  |  | $ | 94.9 |  |  | $ | 12.9 |  |  | $ | (107.8 | ) |  | $ | 77.5 |
Comprehensive income |  | $ | 80.6 |  |  | $ | 97.5 |  |  | $ | 13.4 |  |  | $ | (110.9 | ) |  | $ | 80.6 |
CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS Nine Months Ended September 30, 2014
|  | Parent |  | Guarantor Subsidiaries |  | Non-Guarantor Subsidiaries |  | Consolidating Adjustments |  | Consolidated
Cash flows from operating activities: |  |  |  |  |  |  |  |  |  |
Net cash provided by operating activities |  | $ | 13.9 |  |  | $ | 82.7 |  |  | $ | 7.1 |  |  | $ | — |  |  | $ | 103.7 |
Cash flows from investing activities: |  |  |  |  |  |  |  |  |  |
Capital expenditures |  | — |  |  | (38.1 | ) |  | (1.5 | ) |  | — |  |  | (39.6 | )
Purchase of available for sale securities |  | — |  |  | (53.4 | ) |  | — |  |  | — |  |  | (53.4 | )
Proceeds from disposition of available for sale securities |  | — |  |  | 82.2 |  |  | — |  |  | — |  |  | 82.2 |
Change in restricted cash |  | — |  |  | (0.7 | ) |  | — |  |  | — |  |  | (0.7 | )
Net cash used in investing activities |  | — |  |  | (10.0 | ) |  | (1.5 | ) |  | — |  |  | (11.5 | )
Cash flows from financing activities: |  |  |  |  |  |  |  |  |  |
Excess tax benefit upon vesting of non-vested shares and dividend payment on unvested shares expected to vest |  | — |  |  | 0.8 |  |  | — |  |  | — |  |  | 0.8 |
Cancellation of shares to cover employees’ tax withholdings upon vesting of non-vested shares |  | (2.4 | ) |  | — |  |  | — |  |  | — |  |  | (2.4 | )
Repurchase of common stock |  | (28.7 | ) |  | — |  |  | — |  |  | — |  |  | (28.7 | )
Cash dividend paid to stockholders |  | (19.1 | ) |  | — |  |  | — |  |  | — |  |  | (19.1 | )
Intercompany loan |  | 31.3 |  |  | (22.6 | ) |  | (8.7 | ) |  | — |  |  | — |
Net cash used in financing activities |  | (18.9 | ) |  | (21.8 | ) |  | (8.7 | ) |  | — |  |  | (49.4 | )
Net (decrease) increase in cash and cash equivalents during the period |  | (5.0 | ) |  | 50.9 |  |  | (3.1 | ) |  | — |  |  | 42.8 |
Cash and cash equivalents at beginning of period |  | 5.0 |  |  | 157.7 |  |  | 6.8 |  |  | — |  |  | 169.5 |
Cash and cash equivalents at end of period |  | $ | — |  |  | $ | 208.6 |  |  | $ | 3.7 |  |  | $ | — |  |  | $ | 212.3 |
CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS Nine Months Ended September 30, 2013
|  | Parent |  | Guarantor Subsidiaries |  | Non-Guarantor Subsidiaries |  | Consolidating Adjustments |  | Consolidated
Cash flows from operating activities: |  |  |  |  |  |  |  |  |  |
Net cash (used in) provided by operating activities |  | $ | (15.6 | ) |  | $ | 102.8 |  |  | $ | 3.4 |  |  | $ | — |  |  | $ | 90.6 |
Cash flows from investing activities: |  |  |  |  |  |  |  |  |  |
Capital expenditures |  | — |  |  | (44.8 | ) |  | (2.2 | ) |  | — |  |  | (47.0 | )
Purchase of available for sale securities |  | — |  |  | (201.8 | ) |  | — |  |  | — |  |  | (201.8 | )
Proceeds from disposition of available for sale securities |  | — |  |  | 170.7 |  |  | — |  |  | — |  |  | 170.7 |
Change in restricted cash |  | — |  |  | 0.7 |  |  | — |  |  | — |  |  | 0.7 |
Net cash used in investing activities |  | — |  |  | (75.2 | ) |  | (2.2 | ) |  | — |  |  | (77.4 | )
Cash flows from financing activities: |  |  |  |  |  |  |  |  |  |
Excess tax benefit upon vesting of non-vested shares and dividend payment on unvested shares expected to vest |  | — |  |  | 1.0 |  |  | — |  |  | — |  |  | 1.0 |
Cancellation of shares to cover employees’ tax withholdings upon vesting of non-vested shares |  | (2.4 | ) |  | — |  |  | — |  |  | — |  |  | (2.4 | )
Repurchase of common stock |  | (43.9 | ) |  | — |  |  | — |  |  | — |  |  | (43.9 | )
Cash dividend paid to stockholders |  | (17.3 | ) |  | — |  |  | — |  |  | — |  |  | (17.3 | )
Cash dividend returned to the Company |  | 0.6 |  |  | — |  |  | — |  |  | — |  |  | 0.6 |
Intercompany loan |  | 78.6 |  |  | (77.5 | ) |  | (1.1 | ) |  | — |  |  | — |
Net cash provided by (used in) financing activities |  | 15.6 |  |  | (76.5 | ) |  | (1.1 | ) |  | — |  |  | (62.0 | )
Net (decrease) increase in cash and cash equivalents during the period |  | — |  |  | (48.9 | ) |  | 0.1 |  |  | — |  |  | (48.8 | )
Cash and cash equivalents at beginning of period |  | 5.0 |  |  | 266.0 |  |  | 2.4 |  |  | — |  |  | 273.4 |
Cash and cash equivalents at end of period |  | $ | 5.0 |  |  | $ | 217.1 |  |  | $ | 2.5 |  |  | $ | — |  |  | $ | 224.6 |

X
- Details
Name: | kalu_GuarantorAndNonGuarantorFinancialStatementAbstract
Namespace Prefix: | kalu_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of condensed financial statements, including, but not limited to, the balance sheet, income statement, and statement of cash flows. + References No definition available. + Details
Name: | us-gaap_ScheduleOfCondensedFinancialStatementsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration